{"schema_version":2,"canonical_url":"https://asc.understandingaccounting.org/asc/470/954/","source":"FASB Accounting Standards Codification, Basic View","usage":"Study and research edition. Verify current requirements with the official source. Summaries, enrichment, and tags are machine-generated study aids. Paragraph html preserves source markup; snippet is abbreviated. Pending content is not necessarily effective.","number":"470-954","topic":"470","title":"Health Care Entities","area":"Liabilities","paragraphs":6,"summary":"This Subtopic gives health care entity-specific debt guidance, principally for tax-exempt bond financings. Bonds issued by a financing authority for a health care entity's benefit are recorded as a liability (or lease liability) only if the entity is responsible for repayment; otherwise the proceeds are reported as contributions from the sponsoring entity. It also addresses arbitrage rebate liabilities owed to the U.S. Treasury and the accounting for crossover refundings.","concepts":["tax-exempt bond financing","arbitrage rebate liability","crossover refunding","advance refunding","conduit debt obligation","defeasance","contributions from sponsoring entity","offsetting of assets and liabilities"],"categories":["Recognition","Derecognition","Presentation","Industry-specific"],"level":"intermediate","topic_title":"Debt","sections":[{"number":"00","label":"00 Status","anchor":"00-status","is_sec":false,"groups":[{"block":null,"heading":null,"paragraphs":[{"citation":"470-954-00-1","para":"00-1","html":"<div class=\"asc-body\"><div class=\"norm-text\">The following table identifies the changes made to this Subtopic.</div><div class=\"norm-text\"><table class=\"asc-table\" id=\"SL6250448-165483\"><tr><td class=\"entry\"><strong class=\"ph b\">Paragraph</strong></td><td class=\"entry\"><strong class=\"ph b\">Action</strong></td><td class=\"entry\"><strong class=\"ph b\">Accounting Standards Update</strong></td><td class=\"entry\"><strong class=\"ph b\">Date</strong></td></tr><tr><td class=\"entry\"></td><td class=\"entry\"></td><td class=\"entry\"></td><td class=\"entry\"></td></tr><tr><td class=\"entry\"><a href=\"/glossary/a/#advance-refunding\" class=\"term\" title=\"A transaction involving the issuance of new debt to replace existing debt with the proceeds from the new debt placed in trust or otherwise restricted to retire the existing debt at a determinable future date or dates.\"><span>Advance Refunding</span></a></td><td class=\"entry\">Added</td><td class=\"entry\"><a href=\"/updates/asu-2016-02/\" class=\"xref\">Accounting Standards Update No. 2016-02</a></td><td class=\"entry\">02/25/2016</td></tr><tr><td class=\"entry\"><a href=\"/glossary/c/#conditional-contribution\" class=\"term\" title=\"A contribution that contains a donor-imposed condition.\"><span>Conditional Contribution</span></a></td><td class=\"entry\">Added</td><td class=\"entry\"><a href=\"/updates/asu-2018-08/\" class=\"xref\">Accounting Standards Update No. 2018-08</a></td><td class=\"entry\">06/21/2018</td></tr><tr><td class=\"entry\"><a href=\"/glossary/c/#contribution\" class=\"term\" title=\"An unconditional transfer of cash or other assets, as well as unconditional promises to give, to an entity or a reduction, settlement, or cancellation of its liabilities in a voluntary nonreciprocal transfer by another entity acting other than as an owner. Those characteristics distinguish contributions from:Exchange transactions, which are reciprocal transfers in which each party receives and sacrifices approximately commensurate valueInvestments by owners and distributions to owners, which are nonreciprocal transfers between an entity and its ownersOther nonreciprocal transfers, such as impositions of taxes or legal judgments, fines, and thefts, which are not voluntary transfers. In a contribution transaction, the resource provider often receives value indirectly by providing a societal benefit although that benefit is not considered to be of commensurate value. In an exchange transaction, the potential public benefits are secondary to the potential direct benefits to the resource provider. The term contribution revenue is used to apply to transactions that are part of the entity's ongoing major or central activities (revenues), or are peripheral or incidental to the entity (gains). See also Inherent Contribution and Conditional Contribution.\"><span>Contribution</span></a></td><td class=\"entry\">Amended</td><td class=\"entry\"><a href=\"/updates/asu-2018-08/\" class=\"xref\">Accounting Standards Update No. 2018-08</a></td><td class=\"entry\">06/21/2018</td></tr><tr><td class=\"entry\"><a href=\"/glossary/c/#contribution\" class=\"term\" title=\"An unconditional transfer of cash or other assets, as well as unconditional promises to give, to an entity or a reduction, settlement, or cancellation of its liabilities in a voluntary nonreciprocal transfer by another entity acting other than as an owner. Those characteristics distinguish contributions from:Exchange transactions, which are reciprocal transfers in which each party receives and sacrifices approximately commensurate valueInvestments by owners and distributions to owners, which are nonreciprocal transfers between an entity and its ownersOther nonreciprocal transfers, such as impositions of taxes or legal judgments, fines, and thefts, which are not voluntary transfers. In a contribution transaction, the resource provider often receives value indirectly by providing a societal benefit although that benefit is not considered to be of commensurate value. In an exchange transaction, the potential public benefits are secondary to the potential direct benefits to the resource provider. The term contribution revenue is used to apply to transactions that are part of the entity's ongoing major or central activities (revenues), or are peripheral or incidental to the entity (gains). See also Inherent Contribution and Conditional Contribution.\"><span>Contribution</span></a></td><td class=\"entry\">Amended</td><td class=\"entry\"><a href=\"/updates/asu-2010-07/\" class=\"xref\">Accounting Standards Update No. 2010-07</a></td><td class=\"entry\">01/28/2010</td></tr><tr><td class=\"entry\"><a href=\"/glossary/d/#donor-imposed-condition\" class=\"term\" title=\"A donor stipulation (donors include other types of contributors, including makers of certain grants) that represents a barrier that must be overcome before the recipient is entitled to the assets transferred or promised. Failure to overcome the barrier gives the contributor a right of return of the assets it has transferred or gives the promisor a right of release from its obligation to transfer its assets.\"><span>Donor-Imposed Condition</span></a></td><td class=\"entry\">Added</td><td class=\"entry\"><a href=\"/updates/asu-2018-08/\" class=\"xref\">Accounting Standards Update No. 2018-08</a></td><td class=\"entry\">06/21/2018</td></tr><tr><td class=\"entry\"><a href=\"/glossary/p/#promise-to-give\" class=\"term\" title=\"A written or oral agreement to contribute cash or other assets to another entity. A promise carries rights and obligations—the recipient of a promise to give has a right to expect that the promised assets will be transferred in the future, and the maker has a social and moral obligation, and generally a legal obligation, to make the promised transfer. A promise to give may be either conditional or unconditional.\"><span>Promise to Give</span></a></td><td class=\"entry\">Added</td><td class=\"entry\"><a href=\"/updates/asu-2018-08/\" class=\"xref\">Accounting Standards Update No. 2018-08</a></td><td class=\"entry\">06/21/2018</td></tr><tr><td class=\"entry\"></td><td class=\"entry\"></td><td class=\"entry\"></td><td class=\"entry\"></td></tr><tr><td class=\"entry\"><a href=\"/asc/470/954/#470-954-25-1\" class=\"xref\">954-470-25-1</a></td><td class=\"entry\">Amended</td><td class=\"entry\"><a href=\"/updates/asu-2016-02/\" class=\"xref\">Accounting Standards Update No. 2016-02</a></td><td class=\"entry\">02/25/2016</td></tr><tr><td class=\"entry\"><a href=\"/asc/470/954/#470-954-40-1\" class=\"xref\">954-470-40-1</a></td><td class=\"entry\">Amended</td><td class=\"entry\"><a href=\"/updates/asu-2016-02/\" class=\"xref\">Accounting Standards Update No. 2016-02</a></td><td class=\"entry\">02/25/2016</td></tr></table></div></div>","snippet":"The following table identifies the changes made to this Subtopic.\nParagraph | Action | Accounting Standards Update | Date |\n| | | |\nAdvance Refunding | Added | Accounting Standards Update No. 2016-02 | 02/25/2016 |\nCondi…","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:87dbb8599de5930bf2c54f28ab3be27291047ef13eef7aec51e8527b67eef453","downloaded_from":"2026-09-10T00:34:33.725Z","last_downloaded_at":"2026-09-10T00:34:33.725Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477929","source_sha256":"d9bce3c7bbab4b51a65a6c7a3e74dd0c4ef561b7424be84effaa96abf114b561"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:e8e2daf061c44f5b05c09f9bba33e78b2785a21f9074ae7b8a303111b1251450","downloaded_from":"2026-09-10T00:34:33.725Z","last_downloaded_at":"2026-09-10T00:34:33.725Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477929","source_sha256":"d9bce3c7bbab4b51a65a6c7a3e74dd0c4ef561b7424be84effaa96abf114b561"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:7e043c7bdbd2c3ad89f37ef354eb6ea679f7ed2820dff53be2c675e8d41608ea","downloaded_from":"2026-09-10T00:34:33.725Z","last_downloaded_at":"2026-09-10T00:34:33.725Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477929","source_sha256":"d9bce3c7bbab4b51a65a6c7a3e74dd0c4ef561b7424be84effaa96abf114b561"}},{"number":"05","label":"05 Overview and Background","anchor":"05-overview-and-background","is_sec":false,"groups":[{"block":null,"heading":null,"paragraphs":[{"citation":"470-954-05-1","para":"05-1","html":"<div class=\"asc-body\"><div class=\"norm-text\">This Subtopic provides guidance on accounting for debt for health care entities within the scope of this Topic.</div></div>","snippet":"This Subtopic provides guidance on accounting for debt for health care entities within the scope of this Topic.","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:9e632d9d340f30ac2cea56d372d56de25078e3253354570620750461f3d4c636","downloaded_from":"2026-09-10T00:34:36.180Z","last_downloaded_at":"2026-09-10T00:34:36.180Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477840","source_sha256":"97d12722f507f0b53a65552b45413c87451f853f51852f7e9b3c95ea144215a8"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:f022be33de5d1a91081ff935ac8d023c343cdd0c2b8914e55409e8df361f0efa","downloaded_from":"2026-09-10T00:34:36.180Z","last_downloaded_at":"2026-09-10T00:34:36.180Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477840","source_sha256":"97d12722f507f0b53a65552b45413c87451f853f51852f7e9b3c95ea144215a8"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:1d8fe6f360ce24254c86c5c09af3275a1f6b7370c1fdb82240942511b71b3980","downloaded_from":"2026-09-10T00:34:36.180Z","last_downloaded_at":"2026-09-10T00:34:36.180Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477840","source_sha256":"97d12722f507f0b53a65552b45413c87451f853f51852f7e9b3c95ea144215a8"}},{"number":"15","label":"15 Scope and Scope Exceptions","anchor":"15-scope-and-scope-exceptions","is_sec":false,"groups":[{"block":null,"heading":"Overall Guidance","paragraphs":[{"citation":"470-954-15-1","para":"15-1","html":"<div class=\"asc-body\"><div class=\"norm-text\">This Subtopic follows the same Scope and Scope Exceptions as outlined in the Overall Subtopic, see Section <a altsource=\"GUID-01767497-DC99-41A9-BBB5-8E9F5C2009B6.ditamap\" class=\"ditamap\">954-10-15</a>.</div></div>","snippet":"This Subtopic follows the same Scope and Scope Exceptions as outlined in the Overall Subtopic, see Section 954-10-15.","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:7a7ac20fe05f85d0c52000ab84651509e66797f5c94728372e50d14239d0d202","downloaded_from":"2026-09-10T00:34:38.857Z","last_downloaded_at":"2026-09-10T00:34:38.857Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478748","source_sha256":"665ef4d45d480ad4f8724e88bf2a2a3faaecf852e30dbeb20a4fef3af44c8e8a"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:bce0f6849627e55f4918ff70273ed9851fb8e3a22b5b621f20168c3a8fb96919","downloaded_from":"2026-09-10T00:34:38.857Z","last_downloaded_at":"2026-09-10T00:34:38.857Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478748","source_sha256":"665ef4d45d480ad4f8724e88bf2a2a3faaecf852e30dbeb20a4fef3af44c8e8a"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:8016e056fdd6985e4dc6726b249822a36be7fd2626cf9a01c7f85938b9368663","downloaded_from":"2026-09-10T00:34:38.857Z","last_downloaded_at":"2026-09-10T00:34:38.857Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478748","source_sha256":"665ef4d45d480ad4f8724e88bf2a2a3faaecf852e30dbeb20a4fef3af44c8e8a"}},{"number":"25","label":"25 Recognition","anchor":"25-recognition","is_sec":false,"groups":[{"block":null,"heading":"Financing Authorities","paragraphs":[{"citation":"470-954-25-1","para":"25-1","html":"<div class=\"asc-body\"><div class=\"norm-text\"> <span class=\"sfragment\" id=\"sfr_2811B4BA-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">When a financing authority issues tax-exempt bonds or similar debt instruments and uses the proceeds for the benefit of a health care entity, the obligation shall be reported as a liability in the entity's balance sheet if the health care entity is responsible for repayment. </span></span> <span class=\"sfragment\" id=\"sfr_2811B5F3-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">In some cases, this obligation may take the form of a liability arising from a lease. </span></span> <span class=\"sfragment\" id=\"sfr_2811B71B-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">If a health care entity has no obligation to make payments of principal and interest on the debt or lease payments on related buildings or equipment, the entity shall not reflect the liability on its balance sheet. </span></span> <span class=\"sfragment\" id=\"sfr_2811B851-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">In such circumstances, proceeds from the bond issue shall be reported as <a href=\"/glossary/c/#contribution\" class=\"term\" title=\"An unconditional transfer of cash or other assets, as well as unconditional promises to give, to an entity or a reduction, settlement, or cancellation of its liabilities in a voluntary nonreciprocal transfer by another entity acting other than as an owner. Those characteristics distinguish contributions from:Exchange transactions, which are reciprocal transfers in which each party receives and sacrifices approximately commensurate valueInvestments by owners and distributions to owners, which are nonreciprocal transfers between an entity and its ownersOther nonreciprocal transfers, such as impositions of taxes or legal judgments, fines, and thefts, which are not voluntary transfers. In a contribution transaction, the resource provider often receives value indirectly by providing a societal benefit although that benefit is not considered to be of commensurate value. In an exchange transaction, the potential public benefits are secondary to the potential direct benefits to the resource provider. The term contribution revenue is used to apply to transactions that are part of the entity's ongoing major or central activities (revenues), or are peripheral or incidental to the entity (gains). See also Inherent Contribution and Conditional Contribution.\"><span>contributions</span></a> from the sponsoring entity. </span></span> </div> </div>","snippet":"When a financing authority issues tax-exempt bonds or similar debt instruments and uses the proceeds for the benefit of a health care entity, the obligation shall be reported as a liability in the entity's balance sheet …","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:10f5f806c32164b2f76f9b95d0dbb345568add33c1bac3fd261f3a129eb3ded9","downloaded_from":"2026-09-10T00:34:45.263Z","last_downloaded_at":"2026-09-10T00:34:45.263Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477440","source_sha256":"9caf6b9879de1bda92db8695028a410f798c69473cfb6ec567e8d890cdea6810"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:bf38c60e27af533a7e642fda0df0f12b7c10440881e5249dd5dd7453bf284e1d","downloaded_from":"2026-09-10T00:34:45.263Z","last_downloaded_at":"2026-09-10T00:34:45.263Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477440","source_sha256":"9caf6b9879de1bda92db8695028a410f798c69473cfb6ec567e8d890cdea6810"}},{"block":null,"heading":"Arbitrage Rebate Liabilities","paragraphs":[{"citation":"470-954-25-2","para":"25-2","html":"<div class=\"asc-body\"><div class=\"norm-text\">Internal Revenue Service (IRS) regulations concerning tax-exempt debt prohibit the yield realized from the investment of the proceeds of such debt from exceeding the interest rate to be paid on such debt. <span class=\"sfragment\" id=\"sfr_2811B9B5-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">Whenever a provider invests tax-exempt bond proceeds and the ultimate yield is higher than the interest rate on the bonds, the provider may be subject to an arbitrage rebate liability. </span></span><span class=\"sfragment\" id=\"sfr_2811BAD7-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">The arbitrage determination is made as of the date of the issue; however, intentional acts undertaken after the date of the issue can disqualify the issue retroactively. </span></span><span class=\"sfragment\" id=\"sfr_2811BC02-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">The earnings in excess of interest expense represent a liability that must be paid to the U.S. Treasury in order for the bonds to maintain their tax-exempt status. </span></span><span class=\"sfragment\" id=\"sfr_2811BD27-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">The arbitrage rebate liability may be a substantial amount if the bond proceeds are not spent as quickly as planned. </span></span><span class=\"sfragment\" id=\"sfr_2811BE58-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">For example, this may occur if a provider encounters a delay in a major construction project. </span></span></div> </div>","snippet":"Internal Revenue Service (IRS) regulations concerning tax-exempt debt prohibit the yield realized from the investment of the proceeds of such debt from exceeding the interest rate to be paid on such debt. Whenever a prov…","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:365afd8d37240b85d80d23beee96de580cc46522c6ba6c2ea94b2fa11ad40aca","downloaded_from":"2026-09-10T00:34:45.263Z","last_downloaded_at":"2026-09-10T00:34:45.263Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477440","source_sha256":"9caf6b9879de1bda92db8695028a410f798c69473cfb6ec567e8d890cdea6810"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:3aeeba6ee927a0f855743155cef3b752b73f928b58af6ae846ff12c0e9306d6d","downloaded_from":"2026-09-10T00:34:45.263Z","last_downloaded_at":"2026-09-10T00:34:45.263Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477440","source_sha256":"9caf6b9879de1bda92db8695028a410f798c69473cfb6ec567e8d890cdea6810"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:b846d4f7590d0066447801ca4a2b2cf33c882d12ba8b80791f161f3f5b3d042c","downloaded_from":"2026-09-10T00:34:45.263Z","last_downloaded_at":"2026-09-10T00:34:45.263Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147477440","source_sha256":"9caf6b9879de1bda92db8695028a410f798c69473cfb6ec567e8d890cdea6810"}},{"number":"40","label":"40 Derecognition","anchor":"40-derecognition","is_sec":false,"groups":[{"block":null,"heading":null,"paragraphs":[{"citation":"470-954-40-1","para":"40-1","html":"<div class=\"asc-body\"><div class=\"norm-text\"> <span class=\"sfragment\" id=\"sfr_28282380-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">In a crossover refunding, because the old bonds are not defeased until the crossover date, no immediate gain or loss shall be recognized. If the retirement dates of the old debt have been established, the call premium, unamortized premium or discount, and initial issue costs shall be recognized systematically in the income statement over the remaining life of the old debt as an adjustment of the cost of borrowing related to the old debt. In addition, the income earned on the funds used to consummate the <a href=\"/glossary/a/#advance-refunding\" class=\"term\" title=\"A transaction involving the issuance of new debt to replace existing debt with the proceeds from the new debt placed in trust or otherwise restricted to retire the existing debt at a determinable future date or dates.\"><span>advance refunding</span></a> and the interest expense on both the old and new debts shall be recognized in the income statement. </span></span> <span class=\"sfragment\" id=\"sfr_282824AA-6E93-1014-A13F-6E4B94C84136\"><span class=\"sfragment-source\">The funds used to consummate the advance refunding shall be reported as an asset and both the old and new debts shall be reported as liabilities. The assets and liabilities shall not be offset.</span></span> </div> </div>","snippet":"In a crossover refunding, because the old bonds are not defeased until the crossover date, no immediate gain or loss shall be recognized. If the retirement dates of the old debt have been established, the call premium, u…","pending":false,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:0e457752bd5d6d722c9e954f0426f63bba9162f7d6017c8984a195cbd9967de1","downloaded_from":"2026-09-10T00:34:48.558Z","last_downloaded_at":"2026-09-10T00:34:48.558Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478541","source_sha256":"d52066b37499c29aee1e0a5d7613a7ae6ccb16259d38fd46297cbcd32f86768e"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:d80f7fc5c2fc5df4294e4e6550365dad3e6f8533f346c2fedabd5e0dc957d7c0","downloaded_from":"2026-09-10T00:34:48.558Z","last_downloaded_at":"2026-09-10T00:34:48.558Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478541","source_sha256":"d52066b37499c29aee1e0a5d7613a7ae6ccb16259d38fd46297cbcd32f86768e"}}],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:16289a8b1738cf72c2e62c73236fb11cd9437b57f53194502b10e017c5a78818","downloaded_from":"2026-09-10T00:34:48.558Z","last_downloaded_at":"2026-09-10T00:34:48.558Z","date_scope":"source_page","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps","source_key":"1943274/2147478541","source_sha256":"d52066b37499c29aee1e0a5d7613a7ae6ccb16259d38fd46297cbcd32f86768e"}}],"enrichment":{"summary":"This Subtopic gives health care entity-specific debt guidance, principally for tax-exempt bond financings. Bonds issued by a financing authority for a health care entity's benefit are recorded as a liability (or lease liability) only if the entity is responsible for repayment; otherwise the proceeds are reported as contributions from the sponsoring entity. It also addresses arbitrage rebate liabilities owed to the U.S. Treasury and the accounting for crossover refundings.","key_points":["Tax-exempt bonds issued by a financing authority for the benefit of a health care entity are reported as a liability on the entity's balance sheet if the entity is responsible for repayment, and that obligation may take the form of a lease liability (470-954-25-1).","If the health care entity has no obligation to pay principal and interest (or related lease payments), no liability is recorded and the bond proceeds are reported as contributions from the sponsoring entity (470-954-25-1).","IRS rules prohibit investment yield on tax-exempt debt proceeds from exceeding the interest rate on the debt; excess earnings create an arbitrage rebate liability payable to the U.S. Treasury to preserve tax-exempt status (470-954-25-2).","The arbitrage determination is made as of the issue date, but intentional post-issuance acts can retroactively disqualify the issue, and the rebate can be substantial if proceeds are spent more slowly than planned (470-954-25-2).","In a crossover refunding, the old bonds are not defeased until the crossover date, so no immediate gain or loss is recognized (470-954-40-1).","If retirement dates of the old debt are established, the call premium, unamortized premium or discount, and initial issue costs are recognized systematically over the remaining life of the old debt as an adjustment of the cost of borrowing (470-954-40-1).","The escrowed funds are reported as an asset and both old and new debts as liabilities, with no offsetting; income on the funds and interest expense on both debts are recognized in the income statement (470-954-40-1)."],"categories":["Recognition","Derecognition","Presentation","Industry-specific"],"audience_level":"intermediate","student_note":"The recurring exam trap is assuming that conduit tax-exempt bond proceeds always create a liability for the health care entity — recognition turns entirely on whether the entity is obligated to repay; if not, the proceeds are contribution revenue. Also remember that a crossover refunding produces no immediate gain or loss and requires gross (non-offset) presentation of the escrow asset and both debts.","related_topics":["954-10","470-50","405-20","958-605","842","210-20"],"key_concepts":["tax-exempt bond financing","arbitrage rebate liability","crossover refunding","advance refunding","conduit debt obligation","defeasance","contributions from sponsoring entity","offsetting of assets and liabilities"],"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:7b381b13ca7f78f239a9926ad090418b55cc66909ee3d44f60c4d08f4340abc9","downloaded_from":"2026-09-10T00:34:33.725Z","last_downloaded_at":"2026-09-10T00:34:48.558Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},"related":[{"number":"470-958","title":"Not-for-Profit Entities","topic_title":"Debt","score":0.7401,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:fb48c63155f7eabc3ac2ae4db0c70f78eba047ed1102cd6315b104f2e2ea4a50","downloaded_from":"2026-09-10T00:34:51.743Z","last_downloaded_at":"2026-09-10T00:34:59.299Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},{"number":"310-954","title":"Health Care Entities","topic_title":"Receivables","score":0.7367,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:cd3543f7086bb99835eb5914e24e236d962e7ce7f84448f4458d7d74b0459fa4","downloaded_from":"2026-09-09T23:31:29.416Z","last_downloaded_at":"2026-09-09T23:32:00.586Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},{"number":"470-980","title":"Regulated Operations","topic_title":"Debt","score":0.7249,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:7960e728c82f224a398f266fee7ad86835b1446558aa8cb7e8cfa8cca6aa660d","downloaded_from":"2026-09-10T00:35:14.586Z","last_downloaded_at":"2026-09-10T00:35:24.744Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},{"number":"210-954","title":"Health Care Entities","topic_title":"Balance Sheet","score":0.7229,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:123855d97bf4d97da9923bbcf7a41bac1eb49aec59b60f2f19845d35f1f499cc","downloaded_from":"2026-09-09T23:02:01.873Z","last_downloaded_at":"2026-09-09T23:02:21.878Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},{"number":"405-954","title":"Health Care Entities","topic_title":"Liabilities","score":0.708,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:e81b0e2710df5cee9d38781aea322b3e71e04b447560c4bbad1c08f04187b39f","downloaded_from":"2026-09-10T00:19:21.041Z","last_downloaded_at":"2026-09-10T00:19:37.991Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},{"number":"815-954","title":"Health Care Entities","topic_title":"Derivatives and Hedging","score":0.6861,"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:ebc9894663de5d2f9c17d0d57ef8fe51901b33acd116a7995017a84fe8881c43","downloaded_from":"2026-09-10T01:40:48.280Z","last_downloaded_at":"2026-09-10T01:41:05.239Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}}],"prev":{"number":"470-944","title":"Financial Services—Insurance","topic_title":"Debt","provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:1cdf6dd5c6eca914df7326de9a884a91df1666c7d565fe2996dc2c43cec3bb98","downloaded_from":"2026-09-10T00:34:11.077Z","last_downloaded_at":"2026-09-10T00:34:31.491Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},"next":{"number":"470-958","title":"Not-for-Profit Entities","topic_title":"Debt","provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:b97d12e6e0a1b31a54fe5db63e7a11929a8652e364547b8f7c5c0b263db38891","downloaded_from":"2026-09-10T00:34:51.743Z","last_downloaded_at":"2026-09-10T00:34:59.299Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}},"provenance":{"source_url":"https://asc.fasb.org/","snapshot_version":"sha256:15aea8165dff9f5ae47d9484f8470588b13b307f56e1d50801bf4d85ec190e3f","record_version":"sha256:c34d2672c6d3ffe3ba62c261d18578e730d9797359fed991345913ca8e111514","downloaded_from":"2026-09-10T00:34:33.725Z","last_downloaded_at":"2026-09-10T00:34:48.558Z","date_scope":"source_page_range","effective_as_of":null,"effective_as_of_status":"Not established by retrieval timestamps"}}